Startup Funding News

Explore funding rounds, the companies behind them and the investors taking part.

Rounds
4,825
All time
Disclosed funding
$368.7B
3770 disclosed amounts
Median round
$14.6M
Of disclosed amounts
4,825 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
SystemHealthtech · United StatesCompany profile

An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments.

An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments.

$20MFundingUndisclosedHealthtechUnited StatesInvestors
WintClimate tech · United StatesCompany profile

An AI water-intelligence system detects leaks and waste across buildings and can shut off water before damage spreads.

An AI water-intelligence system detects leaks and waste across buildings and can shut off water before damage spreads.

$36MSeries DSeries C+Climate techUnited StatesInvestors
AERLINMobility · GermanyCompany profile

A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools.

A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools.

UndisclosedSeedMobilityGermanyInvestors
ImplicityHealthtech · FranceCompany profile

Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices.

Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices.

€35MGrowth equityGrowthHealthtechFranceInvestors
Interbeing, Inc.AI · JapanCompany profile

Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing.

Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing.

~¥50MFundingUndisclosedAIJapanInvestors
HVR EnergyMobility · SpainCompany profile

HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets.

HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets.

€20MSeries AMobilitySpainInvestors
AquaFintech · United StatesCompany profile

Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments.

Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments.

$15MSeries AFintechUnited StatesInvestors
MCatalysisClimate tech · United KingdomCompany profile

MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers.

MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers.

$5MSeedClimate techUnited KingdomInvestors
HarveyAI · United StatesCompany profile

Provides legal infrastructure for law firms and in-house teams

Provides legal infrastructure for law firms and in-house teams

$550MSeries HSeries C+AIUnited StatesInvestors
AllogeneticsBiotech · GermanyCompany profile

Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation.

Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation.

€3.8MPre-Series ASeries ABiotechGermanyInvestors